Shares in Organigram Holdings Inc. were hit hard Tuesday after the cannabis company said its fourth-quarter net revenue is expected to be lower than what the company saw in its third quarter.
The cannabis producer’s shares closed down 89 cents or 19.96 per cent at $3.57 on the Toronto Stock Exchange.
Organigram says it expects net revenue for the quarter ended Aug. 31 to amount to $16.3 million, including $20.0 million of shipments in the quarter and about $3.7 million in provisions for product returns and pricing adjustments.
![Click to play video: 'President and CEO of Cannabis NB says profitability is still a distant goal'](https://i1.wp.com/media.globalnews.ca/videostatic/news/jts6kg7imu-oxpy1lu1g2/NB_LIQUOR_CROWN_CORP_1.jpg?w=1040&quality=70&strip=all)
That compared with net revenue of $24.8 million in the third quarter.
Net revenue for the company’s full financial year is expected to be $80.4 million.
Organigram is expected to report its full results for its financial year on Nov. 25.
Comments